AnalystsDavid Dai
David Dai's Stock Forecasts

Analyst Ranking
Bottom 4%
#4773 out of 4923 analysts
Average Return
-32.36%
Win Rate
15%3 out of 20
Risk vs Reward
Poor
Good

David Dai's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Jdcom IncJD
+122.61%$38.35$85.37
2020-03-16 -
2021-03-17
Buy
Immunocore Holdings PLCIMCR
+3.45%$32.50$31.38
2024-10-23 -
2025-06-30
Strong Sell
Merus NvMRUS
+0.57%$52.30$52.60
2024-10-23 -
2025-06-30
Strong Buy

David Dai Analyst Color

Get additional color on David Dai's coverage of popular stocks

David Dai's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Blueprint Medicines CorpBPMC
2Hold$129.00+0.64%Maintains
a month ago
Iovance Biotherapeutics IncIOVA
2Hold$2.00+16.28%Downgrades
2 months ago
Cullinan Therapeutics IncCGEM
2Strong Buy$24.00+218.73%Maintains
2 months ago
Nuvalent IncNUVL
2Strong Buy$100.00+31.06%Upgrades
4 months ago
Kura Oncology IncKURA
2Strong Buy$14.00+142.63%Maintains
4 months ago
Immunocore Holdings PLCIMCR
1Strong Sell$24.00-23.52%Initiates Coverage On
8 months ago
Perspective Therapeutics IncCATX
1Strong Buy$20.00+481.40%Initiates Coverage On
8 months ago
Nurix Therapeutics IncNRIX
1Strong Buy$35.00+207.29%Initiates Coverage On
8 months ago
Merus NvMRUS
1Strong Buy$72.00+36.88%Initiates Coverage On
8 months ago
Janux Therapeutics IncJANX
1Strong Buy$69.00+198.70%Initiates Coverage On
8 months ago
Ideaya Biosciences IncIDYA
1Strong Buy$50.00+137.87%Initiates Coverage On
8 months ago
Cg Oncology IncCGON
1Strong Buy$60.00+130.77%Initiates Coverage On
8 months ago
Syndax Pharmaceuticals IncSNDX
1Strong Buy$37.00+295.09%Initiates Coverage On
8 months ago
Adicet Bio IncACET
1Buy$28.00N/AInitiates Coverage On
3 years ago
Jounce Therapeutics IncJNCE
1Buy$17.00N/AInitiates Coverage On
3 years ago
Inhibrx IncINBX1
1Buy$40.00N/AInitiates Coverage On
3 years ago
Macrogenics IncMGNX
1Buy$40.00N/AInitiates Coverage On
3 years ago
Nkarta IncNKTX
1Buy$50.00N/AInitiates Coverage On
4 years ago
Jdcom IncJD
1Buy$52.00N/AUpgrades
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.